Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

114
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
114
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

371
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
371
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

149
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
149
Inflammation01:38

Inflammation

57.8K
Overview
57.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide amphiphile nanofibers: advanced drug delivery platforms for cardiovascular therapeutics.

Expert opinion on drug delivery·2026
Same author

Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease.

Journal of the American Heart Association·2025
Same author

The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease.

Vascular medicine (London, England)·2024
Same author

What Surgeons Need to Know About the Recent Updates to the CHEST Guidelines on Antithrombotic Therapy for Venous Thromboembolic Disease and Perioperative Management of Antithrombotic Therapy.

Annals of surgery·2023
Same author

Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021.

Vascular medicine (London, England)·2023
Same author

Peptide Amphiphile Supramolecular Nanofibers Designed to Target Abdominal Aortic Aneurysms.

ACS nano·2022

Related Experiment Video

Updated: Nov 20, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.6K

Nanomaterials to Resolve Atherosclerosis.

Erica B Peters, Melina R Kibbe

    ACS Biomaterials Science & Engineering
    |January 19, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Nanomedicine offers a promising approach to combat atherosclerosis by utilizing advanced nanomaterials for targeted drug delivery. Designing smart nanocarriers is key to actively resolving arterial plaque buildup and improving cardiovascular health.

    Keywords:
    atherosclerosiscardiovascular diseasedrug deliverynanomaterialsnanomedicine

    More Related Videos

    Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
    08:13

    Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

    Published on: March 22, 2016

    10.8K
    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
    09:55

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

    Published on: October 25, 2024

    1.2K

    Related Experiment Videos

    Last Updated: Nov 20, 2025

    Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
    08:01

    Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

    Published on: November 17, 2017

    7.6K
    Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
    08:13

    Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis

    Published on: March 22, 2016

    10.8K
    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
    09:55

    Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

    Published on: October 25, 2024

    1.2K

    Area of Science:

    • Biomaterial Science
    • Nanotechnology
    • Cardiovascular Research

    Background:

    • Cardiovascular disease (CVD) remains the primary global cause of mortality and morbidity.
    • Atherosclerosis, characterized by arterial fatty deposits, is a principal driver of CVD.
    • Nanomedicine presents a novel therapeutic avenue for managing atherosclerotic plaque.

    Purpose of the Study:

    • To review the pathophysiology of atherosclerosis.
    • To highlight key design parameters for nanomaterials in targeted drug delivery.
    • To provide foundational knowledge for biomaterial scientists developing atherosclerosis nanotherapies.

    Main Methods:

    • Literature review of atherosclerosis pathophysiology.
    • Analysis of nanocarrier design principles for atheromatous lesions.
    • Synthesis of current research on targeted therapeutic delivery.

    Main Results:

    • Nanomaterials are essential for targeted and controlled drug release in nanomedicine.
    • Nanocarrier design must align with the unique physiochemical properties of atherosclerotic lesions.
    • Successful strategies focus on enhancing therapeutic efficacy and lesion resolution.

    Conclusions:

    • Optimized nanocarrier design is crucial for advancing nanomedicine beyond slowing atherosclerosis progression.
    • Tailoring nanomaterials to lesion-specific characteristics enables active plaque resolution.
    • This perspective equips scientists to design next-generation nanotherapeutics for atherosclerosis.